Literature DB >> 10385229

Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes.

G X Wang1, X B Zhou, T Eschenhagen, M Korth.   

Abstract

1. The effects of mitoxantrone (MTO), an anticancer drug, on the membrane electrical properties of cardiac myocytes were investigated using the whole-cell clamp technique. 2. In isolated guinea-pig ventricular myocytes, 30 microM MTO induced a time-dependent prolongation of action potential duration (APD) which was occasionally accompanied by early afterdepolarizations. APD prolongation was preserved in the presence of 10 microM tetrodotoxin and showed reverse rate-dependence. 3. Both the inward rectifier K+ current (I(KI)) and the delayed rectifier K+ current (I(K)) of guinea-pig ventricular myocytes were significantly depressed by 30 microM MTO. The rapidly activating component of I(k) (I(Kr)) seemed to be preferentially blocked by MTO. The transient outward current was not affected by MTO in rat ventricular myocytes. 4. Thirty microM MTO had no direct effect on the L-type Ca2+ current (I(Ca(L))), but reversed the inhibitory effect of 1 microM carbamylcholine but not the A1-adenosine receptor agonist (-)-N6-phenylisopropyladenosine (1 microM) on I(Ca(L)) enhanced by 50 nM isoprenaline in guinea-pig ventricular myocytes. In guinea-pig atrial mycotyes, 30 microM MTO inhibited by 93% the muscarinic receptor gated K+ current (I(K,ACh)) evoked by 1 microM carbamylcholine, whereas I(K,ACh) elicited by 100 microM GTPgammaS, a nonhydrolysable GTP analogue, was only decreased by 12%. 5. The specific binding of [3H]QNB, a muscarinic receptor ligand, to human atrial membranes was concentration-dependently displaced by MTO (1-1000 microM). 6. In conclusion, MTO blocks cardiac muscarinic receptors and prolongs APD by inhibition of I(KI) and I(Kr). The occasionally observed early afterdepolarizations may signify a potential cardiac hazard of the drug.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385229      PMCID: PMC1566021          DOI: 10.1038/sj.bjp.0702547

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

Review 1.  The cardiac effects of adenosine.

Authors:  L Belardinelli; J Linden; R M Berne
Journal:  Prog Cardiovasc Dis       Date:  1989 Jul-Aug       Impact factor: 8.194

2.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Authors:  M C Sanguinetti; N K Jurkiewicz
Journal:  J Gen Physiol       Date:  1990-07       Impact factor: 4.086

3.  On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

4.  Short-term desensitization of muscarinic K+ channel current in isolated atrial myocytes and possible role of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1987-10       Impact factor: 3.657

5.  Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex.

Authors:  E H Herman; J Zhang; B B Hasinoff; J R Clark; V J Ferrans
Journal:  J Mol Cell Cardiol       Date:  1997-09       Impact factor: 5.000

6.  Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.

Authors:  I C Henderson; J C Allegra; T Woodcock; S Wolff; S Bryan; K Cartwright; G Dukart; D Henry
Journal:  J Clin Oncol       Date:  1989-05       Impact factor: 44.544

7.  Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes.

Authors:  T Kiyosue; M Arita
Journal:  Circ Res       Date:  1989-02       Impact factor: 17.367

8.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

9.  Methylene blue is a muscarinic antagonist in cardiac myocytes.

Authors:  N Abi-Gerges; T Eschenhagen; L Hove-Madsen; R Fischmeister; P F Mery
Journal:  Mol Pharmacol       Date:  1997-09       Impact factor: 4.436

Review 10.  Mitoxantrone: its development and role in clinical practice.

Authors:  R B Weiss
Journal:  Oncology (Williston Park)       Date:  1989-06       Impact factor: 2.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.